GLENMARK PHARMACEUTICALS LTD. - Board recommends Dividend
12 May 2016
Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2016, inter alia, has recommended Dividend @ 200% i.e. Rs. 2/- per share (face value Re. 1/-) on the Equity Share Capital of the Company for the financial year 2015-2016 subject to the approval of the Shareholders at the ensuing Annual General Meeting.
Source:
BSE India